GSK (LON:GSK) Stock Crosses Above 200 Day Moving Average - Here's Why

Key Points

• GSK shares surged past their 200-day moving average of GBX 1,432.68, reaching as high as GBX 1,519 ($20.63) during trading.
• Analysts have set varying price targets for GSK, with a consensus average target of GBX 1,637.50, while ratings include one Buy, two Holds, and one Sell.
• Insider trading activity included purchases of 1,930 shares by insiders in the past 90 days, indicating confidence in the company's performance.

GSK plc (LON:GSK - Get Free Report)'s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,432.68 ($19.56) and traded as high as GBX 1,519 ($20.73). GSK shares last traded at GBX 1,517.49 ($20.71), with a volume of 4,955,833 shares changing hands.

Analysts Set New Price Targets

Several equities research analysts have issued reports on GSK shares. Berenberg Bank reiterated a "hold" rating and set a GBX 1,600 price objective on shares of GSK in a research note on Friday, July 18th. Shore Capital restated a "buy" rating and set a GBX 2,100 target price on shares of GSK in a report on Wednesday, August 27th. JPMorgan Chase & Co. lowered their price target on GSK from GBX 1,460 to GBX 1,400 and set an "underweight" rating for the company in a report on Monday, August 4th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a GBX 1,450 price objective on shares of GSK in a research report on Thursday, July 31st. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of GBX 1,637.50.

GSK Stock Performance

The firm has a market capitalization of £59.27 billion, a price-to-earnings ratio of 1,779.32, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The firm's 50-day moving average price is GBX 1,431.76 and its two-hundred day moving average price is GBX 1,432.64. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81.

GSK (LON:GSK - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 earnings per share (EPS) for the quarter. GSK had a net margin of 8.02% and a return on equity of 18.08%. Sell-side analysts predict that GSK plc will post 175.980975 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Jonathan Symonds acquired 1,350 shares of the firm's stock in a transaction dated Friday, June 20th. The stock was bought at an average price of GBX 1,435 per share, with a total value of £19,372.50. Also, insider Wendy Becker purchased 545 shares of the company's stock in a transaction that occurred on Friday, June 20th. The stock was acquired at an average price of GBX 1,435 per share, for a total transaction of £7,820.75. In the last ninety days, insiders acquired 1,930 shares of company stock worth $2,769,931. Insiders own 0.20% of the company's stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.